:max_bytes(150000):strip_icc()/Health-GettyImages-904802840-196d0fcc6841444b9c7c979e9140bc34.jpg?w=120&resize=120,86&ssl=1 "Graft vs. Host Disease (GVHD): Symptoms, Treatment, and More")
Focusing on Volume and Revenue Growth with Expanding Margins Amid Lab Expansion: Ameera Shah
In an exclusive interview with ETHealthworld’s Prathiba Raju, Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Ltd, discusses the company’s remarkable performance characterised by strong volume and revenue growth, as well as expanding EBITDA margins, despite the ongoing lab expansion. Shah emphasises that the upcoming year will see a concentrated effort on operational efficiency and strategic investments aimed at sustaining and enhancing margins while continuing to thrive in both core and speciality segments. She shares insights into the strategies driving this success and the company’s vision for the future
